Please login to the form below
bone cancer
This page shows the latest bone cancer news and features for those working in and with pharma, biotech and healthcare.
EC approves Otsuka and Astex’s Inaqovi for acute myeloid leukaemia
AML is a rapidly progressing cancer of the blood and bone marrow and the most common form of acute leukaemia in adults.
Latest news
-
2Seventy bio’s partner pauses phase 1 leukaemia study following patient death
AML is a rapidly progressing cancer of the blood and bone marrow. ... Relapsed AML affects about half of all patients who, following treatment and remission, experience a return of leukaemia cells in the bone marrow.
-
Janssen shares positive phase 3 results for cilta-cel in multiple myeloma
Multiple myeloma is a blood cancer that affects plasma cells – a type of white blood cell – inside the bone marrow. ... The American Cancer Society estimates that over 35, 000 new cases will be diagnosed in the US this year, with over 12, 000 deaths
-
Pfizer reports positive results for elranatamab in multiple myeloma
Pfizer has announced updated results from the MagnetisMM clinical development programme evaluating its investigational cancer immunotherapy, elranatamab, in multiple myeloma. ... Multiple myeloma is a blood cancer that impacts plasma cells – a type of
-
BMS and 2seventy bio report positive phase 3 results for multiple myeloma treatment
Multiple myeloma is a blood cancer that impacts plasma cells – a type of white blood cell – which are found in the bone marrow. ... The American Cancer Society estimates that over 35, 000 new cases of multiple myeloma will be diagnosed in the US this
-
Sandoz’s biosimilar denosumab application accepted by FDA for osteoporosis
A human monoclonal antibody, denosumab, is designed to decrease the production and activity of the cells involved in breaking down bone tissue, resulting in a reduction of bone loss and the ... In addition to being an important medicine for cancer of the
More from news
Approximately 1 fully matching, plus 79 partially matching documents found.
Latest Intelligence
-
Addressing the payer-regulator evidence gap in early-stage cancer
By Jason Ward. In 2018, more than four million people across Europe were diagnosed with some form of cancer. ... These events may include the return of the cancer or the onset of certain symptoms, such as bone pain from cancer that has spread to the bone.
-
Deal Watch September 2016
Dr Reddy's has expanded its collaboration with Amgen in India adding three approved products: Xgeva for treating bone metastases, Vectibix in colorectal cancer therapy and Prolia for osteoporosis. ... Janssen granted Tracon Pharmaceuticals the rights to
-
Case study: Treatment guidance
Mifamurtide is a treatment for children, adolescents and young adults with a rare type of bone cancer, osteosarcoma.
-
Pharma deals during April 2014
Jakavi (rare bone marrow disorder); Signifor (Cushing's disease) plus 16 products in 24 pivotal trials. ... Additional revenues for these two drugs are also promised in other cancer types not to mention their “combo” potential.
-
The distressing impact of rare diseases
A US patient with Multiple Hereditary Exostosis (that can cause bone cancer) quoted in the report said: “Finding a doctor that can treat me is the most difficult part.
More from intelligence
Approximately 0 fully matching, plus 6 partially matching documents found.
Latest from PMHub
-
Life with multiple myeloma - why I'm a lucky man living the dream
To describe yourself as lucky when you’ve been diagnosed as having a rare incurable bone marrow cancer could easily qualify you for a visit from the men in white coats, ... You mean cancer?” I interrupted, sensing that this wasn’t a word he wanted
More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.
Subscribe to our email news alerts
- HCP ENGAGEMENT STUDY: Pharma shifts top priority to HCP insights and impact metrics
- AstraZeneca/Merck’s Lynparza combination recommended by NICE for advanced ovarian cancer
- BMS shares positive phase 3 results for Opdivo/Yervoy combination in colorectal cancer
- Stanford Medicine researchers find blood tests help predict organ failure
- GSK and GCOA report reveals global inequities in adult immunisation uptake
- A “Leaky Pipeline” and the Loss of Talented Female Physicians
No results were found
Latest intelligence
- Clinical Trials Investigator and Patient Engagement Planning: A Customer Story
- ...
- New Playbook Alert: Virtual Patient Engagement
- ...
- Millennials: the wellness generation
- Looking at the results from a global healthcare research study focusing on the patients of the future...
